Oric Pharmaceuticals, Inc. research brief

CIK 1796280 Copy CIK

Generated Nov. 8, 2026, 12:58 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: SOUTH SAN FRANCISCO CA. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• June 6, 2025 · D · 0001796280-25-000001 · Source evidence

  Reported offering amount: 125000000 USD. Reported amount sold: 125000000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Oric Pharmaceuticals, Inc. research brief,” CIK 1796280, retrieved Nov. 8, 2026, 12:58 a.m.. Cite the specific accessions used. No amounts have been summed.